Osve Pharmaceutical

Osve Pharmaceutical is dedicated to enhancing the health of the community through cutting-edge technologies and adherence to international standards. With a focus on treating challenging diseases such as thalassemia, genetic enzyme deficiencies, multiple sclerosis, cancer, and transplant-related conditions, Osve Pharmaceutical provides numerous medications, including Deferasirox (Asveral®), Nitisinone, Glatiramer Acetate (Osvimer®), Imatinib, Capecitabine (Eslooda®), Exemestane (Aromestan®), Mycophenolate (Cytogan®), Erythropoietin (Osvepoietin®), and Bosentan (Botecril®).

Located in Tehran, with its primary address in Saadat Abad, Osve Pharmaceutical prioritizes continuous improvement in drug quality while maintaining affordability for patients, ultimately aiming to satisfy both physicians and patients. The company values the input of professors, specialists, doctors, and patients, and appreciates the trust of the medical community.

Osve Pharmaceutical views the recognition and trust of the esteemed medical community as its most valuable asset, earned through over 40 years of service to the healthcare sector. Osve Pharmaceutical is committed to safeguarding this asset and continually striving to provide excellent healthcare solutions. We invite the manager of Osve Pharmaceutical to create a customized and exclusive company showcase and product listing on our platform to further highlight your contributions to the pharmaceutical industry.